Clinical Trials · NCT05553093
Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Enrollment
- 150
- Start date
- Mar 2022
- Locations
- 1 site, China
- Primary endpoint
- blood sugar changes